Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 03, 2021

SELL
$12.4 - $17.6 $2,790 - $3,960
-225 Closed
0 $0
Q3 2020

Oct 19, 2020

BUY
$11.59 - $14.93 $869 - $1,119
75 Added 50.0%
225 $3,000
Q2 2020

Jul 24, 2020

SELL
$11.79 - $15.97 $23,285 - $31,540
-1,975 Reduced 92.94%
150 $2,000
Q4 2019

Jan 21, 2020

BUY
$13.91 - $21.48 $8,346 - $12,888
600 Added 39.34%
2,125 $43,000
Q3 2019

Nov 06, 2019

SELL
$15.84 - $30.01 $9,504 - $18,006
-600 Reduced 28.24%
1,525 $24,000
Q2 2019

Jul 19, 2019

BUY
$17.38 - $26.88 $36,932 - $57,120
2,125 New
2,125 $57,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $295M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Focused Wealth Management, Inc Portfolio

Follow Focused Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Focused Wealth Management, Inc with notifications on news.